Updates

Cineworld

March 2016

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Cineworld confirmed that it experienced “strong revenue growth” in 2015 with sales up 12% year-on-year. This was broad-based with an 11.6% increase in the UK and 13.7% in Central & Eastern Europe & Israel (CEE) and was helped by the latest releases from Star Wars, James Bond and Hunger Games.Cineworld opened 18 new cinemas in 2015, 10 in the UK and 8 in CEE including its first UK VIP Experience in Sheffield while also increasing the number of IMAX screens to 28 and 4DX screens to 14.In 2016 it’s set to open a further 13 sites, including 6 in UK and 7 in CEE & Israel as well as several major refurbishments.JP Morgan Cazenove forecasts eps of 27.9p in ’15, rising to 32.3p this yea ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Ibstock

Premier Oil - JPâ€ˆMorgan Cazenove introduces 60p price target

Cineworld - Exciting film slate and pent up demand could drive re-rating (September 2021)

Cineworld (April 2020)

Cineworld (February 2020)

Cineworld (September 2019)

Cineworld - Sale and leaseback yields special dividend (July 2019)

Cineworld - Results trigger broker upgrades (May 2019)

Cineworld - Cinema chain transformed by US acquisition (April 2019)

Cineworld (July 2018)

Cineworld - Transformational US acquisition (March 2018)

Cineworld - Cinema operator boosted by Hollywood blockbuster (October 2017)

Cineworld (July 2017)

Cineworld - Acquires five cinemas for Â£94m (October 2016)

Cineworld (May 2016)

Cineworld (October 2015)

Cineworld - Cinema chain to benefit from strong film release schedule (September 2015)

Cineworld - Second largest cinema chain expanding rapidly (July 2015)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X